Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

UV Light-mediated Corneal Crosslinking as (Lymph)Angioregressive Pretreatment to Promote Graft Survival After Subsequent High-risk Corneal Transplantation [CrossCornealVision]

NCT05870566 is registered in ClinicalTrials.gov with Claus Cursiefen as lead sponsor.

NCT NCT05870566
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05870566 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
UV Light-mediated Corneal Crosslinking as (Lymph)Angioregressive Pretreatment to Promote Graft Survival After Subsequent High-risk Corneal Transplantation [CrossCornealVision]
Lead sponsor
Claus Cursiefen
Phase
Not applicable
Overall status
Recruiting
Start date
November 20, 2023
Completion date
September 30, 2028
Enrollment
110 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

corneal transplantation